NasdaqGS - Nasdaq Real Time Price USD

Healthcare Services Group, Inc. (HCSG)

Compare
10.97 -0.08 (-0.72%)
At close: October 31 at 4:00 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
?

Revenue vs. Earnings

Revenue 428.15M
Earnings 14.03M
?

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
?

Analyst Price Targets

12.00
13.75 Average
10.97 Current
17.00 High

Earnings Estimate

CURRENCY IN USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 5455
Avg. Estimate 0.20.210.580.84
Low Estimate 0.190.20.570.81
High Estimate 0.220.240.590.88
Year Ago EPS 0.310.210.520.58

Revenue Estimate

CURRENCY IN USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 5455
Avg. Estimate 435.03M436.95M1.71B1.77B
Low Estimate 432.83M435.9M1.71B1.76B
High Estimate 436.2M438.7M1.71B1.78B
Year Ago Sales 423.84M424.95M1.67B1.71B
Sales Growth (year/est) 2.60%2.80%2.50%3.20%

Earnings History

CURRENCY IN USD 12/31/2023 3/31/2024 6/30/2024 9/30/2024
EPS Est. 0.160.190.20.19
EPS Actual 0.310.21-0.020.19
Difference 0.150.02-0.220
Surprise % 93.80%10.50%-110.00%0.00%

EPS Trend

CURRENCY IN USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate 0.20.210.580.84
7 Days Ago 0.20.210.580.84
30 Days Ago 0.210.220.590.88
60 Days Ago 0.210.220.590.88
90 Days Ago 0.210.220.590.88

EPS Revisions

CURRENCY IN USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days 1--1--
Up Last 30 Days 1--1--
Down Last 7 Days --------
Down Last 30 Days 2134

Growth Estimates

CURRENCY IN USD HCSGIndustrySectorS&P 500
Current Qtr. -35.50%----4.20%
Next Qtr. 0.00%----9.20%
Current Year 11.50%----2.00%
Next Year 44.80%----12.70%
Next 5 Years (per annum) 9.00%----11.68%
Past 5 Years (per annum) -12.29%------

Upgrades & Downgrades

Reiterates Benchmark: Buy to Buy 10/24/2024
Maintains Baird: Neutral to Neutral 10/24/2024
Reiterates Benchmark: Buy to Buy 7/25/2024
Maintains RBC Capital: Outperform to Outperform 7/25/2024
Maintains Baird: Neutral to Neutral 7/25/2024
Maintains Benchmark: Buy to Buy 2/15/2024

Related Tickers